GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) » Definitions » Interest Expense

Bharat Immunologicals & Biologicals (BOM:524663) Interest Expense : ₹-74.49 Mil (TTM As of Sep. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Bharat Immunologicals & Biologicals Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Bharat Immunologicals & Biologicals's interest expense for the three months ended in Sep. 2023 was ₹ -20.87 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was ₹-74.49 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Bharat Immunologicals & Biologicals's Operating Income for the three months ended in Sep. 2023 was ₹ -47.23 Mil. Bharat Immunologicals & Biologicals's Interest Expense for the three months ended in Sep. 2023 was ₹ -20.87 Mil. Bharat Immunologicals & Biologicals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bharat Immunologicals & Biologicals Interest Expense Historical Data

The historical data trend for Bharat Immunologicals & Biologicals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bharat Immunologicals & Biologicals Interest Expense Chart

Bharat Immunologicals & Biologicals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.57 -40.63 -43.64 -51.09 -69.63

Bharat Immunologicals & Biologicals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.42 -16.68 -19.72 -17.21 -20.87

Bharat Immunologicals & Biologicals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-74.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bharat Immunologicals & Biologicals  (BOM:524663) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bharat Immunologicals & Biologicals's Interest Expense for the three months ended in Sep. 2023 was ₹-20.87 Mil. Its Operating Income for the three months ended in Sep. 2023 was ₹-47.23 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2023 was ₹35.00 Mil.

Bharat Immunologicals & Biologicals's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Bharat Immunologicals & Biologicals did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Bharat Immunologicals & Biologicals (BOM:524663) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) » Definitions » Interest Expense
Comparable Companies
BOM:540679 BOM:511509 BOM:526139 BOM:542910 BOM:514336 BOM:539206 BOM:506365 BOM:531207 BOM:532890 BOM:524717 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Village Chola, BIBCOL, OPV Plant, Bulandshahar, UP, IND, 203203
Website
http://www.bibcol.sciencecentral.in
Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.

Bharat Immunologicals & Biologicals (BOM:524663) Headlines

No Headlines